Recently, Chen et al. showed that reversing the methylation of the nuclear receptor subfamily 4 group A member 1 (NR4A1) contributed to its high expression and decreased blood glucose in T2DM patients [66]. This evidence concerns the gene NR4A1 and type 2 diabetes mellitus.